HQL offers a 14.2% dividend yield and diverse exposure to healthcare and life science companies. Since abrdn's acquisition in 2023, HQL has delivered a total return of 25.5%, though its price ...
~ by Snehasish Chaudhuri, MBA (Finance). Tekla Life Sciences Investors (HQL) is a closed-ended equity mutual fund, or CEF, that invests in growth stocks of companies. The fund offers strong and steady ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback